Revance Therapeutics Inc. buy Heureka
Start price
13.01.20
/
50%
€17.50
Target price
31.01.20
€35.00
Performance (%)
15.43%
End price
31.01.20
€20.20
Summary
This prediction ended on 31.01.20 with a price of €20.20. The prediction had a final performance of 15.43%. Heureka has 50% into this predictionPerformance without dividends (%)
Name | 1w | 1m | 1y | 3y |
---|---|---|---|---|
Revance Therapeutics Inc. | - | - | - | - |
iShares Core DAX® | -0.543% | 1.491% | 13.638% | 16.760% |
iShares Nasdaq 100 | -2.696% | -1.235% | 31.879% | 45.155% |
iShares Nikkei 225® | -2.863% | 2.491% | 12.078% | 7.840% |
iShares S&P 500 | -1.105% | 0.013% | 26.888% | 43.056% |
Comments by Heureka for this prediction
In the thread Revance Therapeutics Inc. diskutieren
Buy mit Kursziel 35,0
Buy beendet
Stopped prediction by Heureka for Revance Therapeutics Inc.
Revance Therapeutics Inc.
Start price
Target price
Perf. (%)
€23.40
26.02.20
26.02.20
€30.00
09.03.20
09.03.20
-27.78%
09.03.20
09.03.20
Revance Therapeutics Inc.
Start price
Target price
Perf. (%)
€24.40
10.02.20
10.02.20
€35.00
21.02.20
21.02.20
3.28%
21.02.20
21.02.20